Clinical Trial Update: Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating prinomastat in combination with chemotherapy for metastatic or recurrent non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Prinomastat (prinomastat)

Snippet

Sponsor: Pfizer | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED